Relation between Blood Lead Levels and Hypochromic Microcytic Anemia among Primary School Children
DOI:
https://doi.org/10.24086/cuesj.v10n1y2026.pp24-32Keywords:
Anemic children, iron deficiency anemia, hypochromic microcytic anemia, blood lead level, lead toxicityAbstract
Iron deficiency (ID) and thalassemia are the main causes of hypochromic microcytic anemia (HMA), a common nutritional disorder affecting school-age children. This study compared Group A, hypochromic microcytic children with ID, Group B, hypochromic microcytic children with normal ferritin levels, and control groups to investigate the additional effect of lead exposure on the severity of HMA in children aged 9–12 years. Blood analyses showed that Group A had higher blood lead levels (BLLs) (7.764 μg/dL) and significantly lower iron parameters (serum iron 47.82 ± 3.15 μg/dL and ferritin 14.41 ± 1.329 ng/mL) than controls (86.86 ± 3.003 μg/dL iron, 72.9 ± 5.847 ng/mL ferritin, and 3.175 ± 0.5347 μg/dL BLL; all P < 0.0001). Group B exhibited moderate in comparison to Group A lead exposure (7.54 ± 1.15 μg/dL) and iron-replete but elevated ferritin (118.6 ± 60.75 ng/mL). Lead interferes with iron metabolism, as evidenced by the negative correlation between lead levels and iron status (serum iron r = −0.2281, transferrin saturation r = −0.3141) and the positive correlation with total iron binding capacity (r = 0.32). While Group B children maintain different iron profiles despite similar lead exposure, the results show that environmental lead exposure exacerbates ID in Group A through disrupted absorption and utilization. These findings highlight the importance of concurrent lead screening and iron status evaluation in pediatric HMA management, especially in areas with environmental lead contamination.
Downloads
References
1. Disalvo, L., et al., Blood lead levels and their association with iron deficiency and anemia in children. Biological Trace Element Research, 2025. 203(1): p. 69-75. DOI: https://doi.org/10.1007/s12011-024-04163-y
2. Pradhan, A., C. Aundhakar, and M. Karguppikar, Relation between Blood Lead Levels and Childhood Anemia. Indian J. Public Health Res. Dev, 2022. 13: p. 1-8. DOI: https://doi.org/10.37506/ijphrd.v13i1.17386
3. Elsayed, M., M. Sharif, and A. Stack, Transferrin saturation: a body iron biomarker. Advances in clinical chemistry, 2016. 75: p. 71-97. DOI: https://doi.org/10.1016/bs.acc.2016.03.002
4. Bain, B.J., I. Bates, and M.A. Laffan, Dacie and Lewis Practical Haematology E-Book: Dacie and Lewis Practical Haematology E-Book. 2016: Elsevier Health Sciences.
5. Mei, Z., et al., Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: A network meta-analysis of randomized controlled trials. Pharmacological Research, 2022. 182: p. 106345. DOI: https://doi.org/10.1016/j.phrs.2022.106345
6. Gkamprela, E., M. Deutsch, and D. Pectasides, Iron deficiency anemia in chronic liver disease: etiopathogenesis, diagnosis and treatment. Annals of gastroenterology, 2017. 30(4): p. 405. DOI: https://doi.org/10.20524/aog.2017.0152
7. Urrechaga, E., et al., Reticulocyte hemoglobin content (MCHr) in the assessment of iron deficient erythropoiesis in inflammatory bowel disease. Digestive and Liver Disease, 2018. 50(11): p. 1178-1182. DOI: https://doi.org/10.1016/j.dld.2018.04.010
8. Gadina, M., et al., Janus kinases to jakinibs: from basic insights to clinical practice. Rheumatology, 2019. 58(Supplement_1): p. i4-i16. DOI: https://doi.org/10.1093/rheumatology/key432
9. Putti, M.C., I. Bertozzi, and M.L. Randi, Essential thrombocythemia in children and adolescents. Cancers, 2021. 13(23): p. 6147. DOI: https://doi.org/10.3390/cancers13236147
10. Caprari, P., et al., Hemorheological profiles and chronic inflammation markers in transfusion-dependent and non-transfusion-dependent thalassemia. Frontiers in Molecular Biosciences, 2023. 9: p. 1108896. DOI: https://doi.org/10.3389/fmolb.2022.1108896
11. Taher, A.T., et al., Luspatercept for the treatment of anemia in non-transfusion-dependent β-thalassemia: final safety and efficacy data from the BEYOND trial. Blood, 2023. 142: p. 3847. DOI: https://doi.org/10.1182/blood-2023-174097
12. Peyrin-Biroulet, L., et al., Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues. Therapeutic advances in gastroenterology, 2021. 14: p. 17562848211059954. DOI: https://doi.org/10.1177/17562848211059954
13. Camaschella, C., Iron-deficiency anemia. New England journal of medicine, 2015. 372(19): p. 1832-1843. DOI: https://doi.org/10.1056/NEJMra1401038
14. Cappellini, M., K.M. Musallam, and A.T. Taher, Iron deficiency anaemia revisited. Journal of internal medicine, 2020. 287(2): p. 153-170. DOI: https://doi.org/10.1111/joim.13004
15. Gracia, J., et al., Obesity surgery results depending on technique performed: long-term outcome. Obesity surgery, 2009. 19(4): p. 432-438. DOI: https://doi.org/10.1007/s11695-008-9762-x
16. Taylor, C.M., et al., Maternal diet during pregnancy and blood cadmium concentrations in an observational cohort of British women. Nutrients, 2020. 12(4): p. 904. DOI: https://doi.org/10.3390/nu12040904
17. Kumar, S., et al., Lead and other elements-based pollution in soil, crops and water near a lead-acid battery recycling factory in Bangladesh. Chemosphere, 2022. 290: p. 133288. DOI: https://doi.org/10.1016/j.chemosphere.2021.133288
18. Girelli, D., et al., Hemochromatosis classification: update and recommendations by the BIOIRON Society. Blood, 2022. 139(20): p. 3018-3029. DOI: https://doi.org/10.1182/blood.2021011338
19. Jiang, L., et al., RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation. Blood, The Journal of the American Society of Hematology, 2021. 138(8): p. 689-705. DOI: https://doi.org/10.1182/blood.2020008986
20. An, P., et al., TMPRSS6, but not TF, TFR2 or BMP2 variants are associated with increased risk of iron-deficiency anemia. Human molecular genetics, 2012. 21(9): p. 2124-2131. DOI: https://doi.org/10.1093/hmg/dds028
21. Peyrin-Biroulet, L., et al., Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Official journal of the American College of Gastroenterology| ACG, 2015. 110(9): p. 1324-1338. DOI: https://doi.org/10.1038/ajg.2015.233
22. Covid, C., et al., COVID-19 vaccine breakthrough infections reported to CDC—United States, January 1–April 30, 2021. Morbidity and Mortality Weekly Report, 2021. 70(21): p. 792. DOI: https://doi.org/10.15585/mmwr.mm7021e3
23. Ogun, A.S., N.V. Joy, and M. Valentine, Biochemistry, heme synthesis, in StatPearls [Internet]. 2023, StatPearls Publishing.
24. Mokhtar, G., et al., Transfusion of blood components in pediatric age groups: an evidence-based clinical practice guideline adapted for the use in Egypt using ‘Adapted ADAPTE’. Annals of Hematology, 2024. 103(4): p. 1373-1388. DOI: https://doi.org/10.1007/s00277-024-05657-4
25. Shubham, S., et al., Role of air pollution in chronic kidney disease: an update on evidence, mechanisms and mitigation strategies. International Archives of Occupational and Environmental Health, 2022. 95(5): p. 897-908. DOI: https://doi.org/10.1007/s00420-021-01808-6
26. Larsen, B. and E. Sánchez-Triana, Global health burden and cost of lead exposure in children and adults: a health impact and economic modelling analysis. The Lancet Planetary Health, 2023. 7(10): p. e831-e840. DOI: https://doi.org/10.1016/S2542-5196(23)00166-3
27. Zhai, Q., et al., Oral supplementation of lead-intolerant intestinal microbes protects against lead (Pb) toxicity in mice. Frontiers in microbiology, 2020. 10: p. 3161. DOI: https://doi.org/10.3389/fmicb.2019.03161
28. Lee, H.J. and H.-Y. Lee, Characterization of lung function impairment and pathological changes induced by chronic lead and cadmium inhalation: insights from a mouse model study. Ecotoxicology and Environmental Safety, 2024. 283: p. 116776. DOI: https://doi.org/10.1016/j.ecoenv.2024.116776
29. Arshad, S., A. Arif, and J.I. Wattoo, Response of iron deficiency markers to blood lead levels and synergistic outcomes at prenatal stage. Dose-Response, 2022. 20(2): p. 15593258221101744. DOI: https://doi.org/10.1177/15593258221101744
30. Rahman, S.U., et al., Toxic effects of lead (Pb), cadmium (Cd) and tetracycline (TC) on the growth and development of Triticum aestivum: A meta-analysis. Science of the Total Environment, 2023. 904: p. 166677. DOI: https://doi.org/10.1016/j.scitotenv.2023.166677
31. Wani, K.I., et al., Insights into strigolactone (GR24) mediated regulation of cadmium-induced changes and ROS metabolism in Artemisia annua. Journal of Hazardous Materials, 2023. 448: p. 130899. DOI: https://doi.org/10.1016/j.jhazmat.2023.130899
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Mohammed K. Hamza, Nadir M.Q. Nanakali
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
